Illumina, Inc. ILMN launched the TruSight Oncology (“TSO”) Comprehensive (EU)— a single test that evaluates multiple tumor genes and biomarkers to identify the specific molecular profile of a ...
Illumina, Inc. announced the launch of TruSight Oncology (TSO) Comprehensive (EU), a single test that assesses multiple tumour genes and biomarkers to reveal the specific molecular profile of a ...
Illumina, Inc., a global leader in DNA sequencing and array-based technologies, announced the addition of a companion diagnostic (CDx) indication to its CE-marked in vitro diagnostic TruSight Oncology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback